Chartis: Counting and Cutting the Cost of Compliance II

Financial Institutions (FIs) exist in a challenging environment. Following the last financial crisis, multiple waves of new national and supranational regulation have constricted FIs’ profits through, for example, the imposition of minimum capital requirements. Simultaneously, they have driven up general compliance expenditure. And, as regulations have continued to proliferate, most firms acknowledge that it is not enough merely to comply with current regulations – they must budget for future

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risktech Forum? Register for access

RiskTech100® Winner’s Profile: Moody's

Moody’s celebrates its first year at the top of the RiskTech100 rankings. This marks a stellar year for the Overall Winner, with the firm taking home 15 additional individual awards, its largest haul in the 17-year history of the RiskTech100.

RiskTech100® Rising Star Profile: Vneuron

Vneuron Risk & Compliance is a ‘Rising Star’ in this year’s Chartis’ RiskTech100 awards. The fast-growing, French-headquartered firm is on a mission to fight money laundering and combat terrorism financing. It has been recognized by Chartis for the…

Chartis Big Bets 2022

Chartis’ annual Big Bets report outlines our major predictions for the year ahead, highlighting some of the key market trends, risk areas and core technologies that form the basis of our 2022 report agenda.

You need to sign in to use this feature. If you don’t have a RiskTech Forum account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can contact us to request an individual account here.